U.S. Exosomes Market Size Poised To Reach USD 575.85 Million By 2030


 San Francisco, 31 December 2024: The Report U.S. Exosomes Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services), By Application (Cancer, CVD), By Workflow (Isolation Methods, Downstream Analysis), By End-use, And Segment Forecasts, 2024 - 2030

The U.S. exosomes market size to reach USD 575.85 million in 2030 and is expected to grow at a CAGR of 34.20% from 2024 to 2030. Exosome applications are advancing, which is driving market growth. Technological advancements in exosome isolation and analytical procedures are contributing to market growth and fueled by the increasing prevalence of cancer. In addition, government and non-government grants for exosome research will likely offer growth opportunities in the market.

The U.S. accounted for 52.0% of the global exosomes market share. The pharmaceutical sector's increasing interest in exosome-based treatments is driving market growth. Exosomes are now recognized as promising therapeutics for cancer, cardiovascular diseases, inflammation, and neurodegenerative disorders. They facilitate the targeted delivery of therapies, enhancing precision and efficacy. Moreover, exosomes are valuable biomarkers for diagnosing and monitoring diseases, reflecting cell status and aiding in early detection and disease progression tracking. These applications accelerate the demand for exosomes in this market.

In the U.S., companies focus on collaborations with research institutions and filing patent applications for exosome-based projects. The market growth is supported by funding agencies like the National Institutes of Health (NIH), which provide grants for exosome R&D. The increasing prevalence of neurodegenerative diseases, cancer, cardiovascular, and infectious diseases is driving the innovative use of exosomes in diagnostics and therapeutics, positively impacting market growth in the region.

Access Research Report of U.S. Exosomes Market @ https://www.grandviewresearch.com/industry-analysis/us-exosomes-market-report

Recent Developments

  • In January 2024, Capricor Therapeuticsrevealed a collaboration with the National Institutes of Health to conduct a clinical trial on a new exosome-based multivalent vaccine for SARS-CoV-2. Capricor's exclusive StealthX™ exosome-based multivalent vaccine for preventing SARS-CoV-2 has been chosen to participate in Project NextGen.
  • In January 2023, Sartoriuspartnered with RoosterBio to enhance downstream purification methods for exosome manufacturing. This collaboration aims to provide top-tier solutions and knowledge for an hMSC-based exosome production platform, ensuring superior yield, purity, and potency.

Key U.S. Exosomes Company Insights

Key companies in the U.S. exosome market include Danaher, Thermo Fisher Scientific, Inc., Hologic, and RoosterBio, Inc., among others. The tense competition in the market is characterized by rapid technological advancements in exosome isolation technologies, which boost the efficiency, accuracy, and throughput of isolation processes, contributing to market growth in the forecast period. Moreover, product offerings through strategic initiatives like innovative product launches, mergers, acquisitions, and partnerships to diversify their portfolios support the market expansion.

Key U.S. Exosomes Companies:

  • Danaher
  • Thermo Fisher Scientific, Inc.
  • Hologic Inc.
  • Bio-Techne
  • RoosterBio, Inc
  • Aragen Bioscience
  • Capricor Therapeutics
  • Coya Therapeutics
  • Aegle Therapeutics Corporation
  • Aethlon Medical

About Grand View Research

Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For More Information: https://www.grandviewresearch.com/horizon

Comments

Post a Comment

Popular posts from this blog

U.K. Point Of Sale Software Market To Expand Industry Growth At USD 1.05 Billion By 2028

Image
  San Francisco, 21 Jan 2022:   The Report  U.K. Point Of Sale Software Market  Size, Share & Trends Analysis Report By Application (Fixed POS, Mobile POS), By Deployment, By Organization Size, By End-user, And Segment Forecasts, 2021 - 2028 The global U.K. point of sale software market size is expected to reach USD 1.05 billion by 2028, expanding at a CAGR of 8.1% from 2021 to 2028, according to the new study conducted by Grand View Research, Inc. The integration of a Point-Of-Sale (POS) solution with capabilities such as sales reports monitoring, cash flow recording, product demand analysis, tracking delivery status, and inventory management ensure systematic functioning and upscaling of a business. The adoption of POS software is directly impacted by the demand for POS terminals, which is witnessing growth in demand due to changing lifestyles and government policies. However, the COVID-19 pandemic disrupted the industry's business, wherein ...
Read more

Gas Detection Equipment Market Anticipated To Expand At A CAGR 9.7% From 2021 To 2028

  San Francisco, 5 May 2021:   The Report  Gas Detection Equipment Market  Size, Share & Trends Analysis Report By Product, By Technology (Infrared, Catalytic, PID), By End-use, By Region, And Segment Forecasts, 2021 - 2028 The global gas detection equipment market size is expected to reach USD 8.38 billion by 2028, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 9.7% from 2021 to 2028. The market growth can be attributed to the growing awareness among governments regarding the harmful effects of greenhouse gases, coupled with their increased efforts toward protecting the environment. Major industries such as petroleum, oil, and gas, among others are needed to comply with safety and environmental regulations which are also major factors driving the market growth. Many companies are focused on introducing drone-based gas detection equipment, which is expected to create new opportunities for market growth in...
Read more